Cancer Testing Kits
Applied Biotech produces molecular pathology cancer testing kits. Each kit contains approximately 22 component parts including buffers, Luminex magnetic beads and RNA probes. Each kit includes 90 tests, plus a control and has a shelf life of 12 months after manufacture.
Applied Biotech INNOPLEX HER2 Confirmatory Test (RUO)
Applied Biotech INNOPLEX HER2 Confirmatory Test (IVD)
Available November 2020. Register your interest via the Contact Form.
Applied Biotech INNOPLEX Molecular Classification of Breast Cancer Test -MCBC (RUO)
HER2, ER and PR. HER2 measurement can also be used for Gastric Cancer. Available from June 2020. Register your interest via the Contact Form.
Applied Biotech INNOPLEX Molecular Classification of Breast Cancer Test -MCBC (IVD)
Available from June 2021. Register your interest via the Contact Form.
Applied Biotech INNOPLEX Colorectal test (MC-CRC) (RUO)
A single test to classify colorectal cancer (Subgroups: Microsatellite instable, Stem-cell like, Enterocyte, inflammatory and goblet cell-like).
Available from June 2020.
Register your interest via the Contact Form.
Applied Biotech INNOPLEX Colorectal test (MC-CRC) (IVD)
A single test to classify colorectal cancer (Subgroups: Microsatellite instable, Stem-cell like, Enterocyte, inflammatory and goblet cell-like). Availale from June 2021.
Register your interest via the Contact Form.
INNOPLEX research only and in vitro biopsy cancer tests covering the following cancers; brain (Glioblastoma multiforme) and lung will launch in 2020-21. TEVIPLEX early cancer screening and ongoing monitoring through simple blood tests will be available from 2021. Please register your interest via our contact forrm.
Would you like to contact us?
Please get in touch to find out more about new test launch dates.